Boston-Based Moderna Delivers Promising Vaccine News

Boston-based Moderna says preliminary data from its coronavirus vaccine trials show 94.5% efficacy.  That's a big number, and it follows a similar announcement from another vaccine partnership last week. WBUR's Angus Chen tells us more.